How J+D delivered a long-term forecasting model sooner than ever before using proprietary software tool

7th April 2022
J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
Read More